Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ditto. I think they get their rocks off. We traded Monday in the low 7’s and today we closed over 9. Volume was incredible this week and volume today was up almost 3 times compared to last Friday which is usually a slow day. I’m glad it’s moving slowly so it doesn’t look like where getting hyped up like Tilray. I’d be selling Tilray, but here I’m happy holding on for the ride. Long and strong Aurora.
The bloated gains from Tilray and Tilray getting halted more than once today spooked the entire mj community. IMO
Volume at all time high. Can't wait till we up list, put out the 10Q, and maybe add a partner, all looking good here.
Insert from that report: A prominent player within the industry, Aurora Cannabis, Inc. (OTC: ACBFF) is making the most of a young market to rapidly expand its business. A $150 million loan from the Bank of Montreal is giving it a short-term financial boost to get ahead of the long-term game. It’s this sort of long-term thinking that has led the company to acquisitions such as the takeover of MedReleaf, increasing Aurora’s market share. Some commentators have compared this strategy with that of Amazon, focusing on market dominance as the route to profit.
Canadian Cannabis Legalization Set to Transform the Industrial Hemp Industry
Date : 09/19/2018 @ 8:45AM
Source : NetworkNewsWire
Stock : Aurora Cannabis Inc. (QX) (ACBFF)
Quote : 8.51 0.0 (0.00%) @ 7:42AM
Canadian Cannabis Legalization Set to Transform the Industrial Hemp Industry
Print
Alert
CannabisNewsWire Editorial Coverage: The legalization of cannabis in Canada is about to bring big changes not just for medical cannabis companies but for hemp growers as well.
The law legalizing recreational cannabis in Canada will come into force on October 17.
This will create new opportunities for hemp growers to produce the plant for CBD extraction.
Hemp growers will now be able to profit from all parts of the plant.
Cannabis companies are experimenting with growing techniques, expanding their businesses, and seeking supply agreements in preparation for the change.
Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile), which grows industrial hemp in Canada, will now be able to sell leaves and flowers as well as other parts of its plants, and is preserving this year’s crop in preparation for the change. In the United States, Isodiol International, Inc. (OTC: ISOLF) is raising the profile of the industry through a celebrity partnership and the expansion of its retail chain. Aurora Cannabis, Inc. (OTC: ACBFF) has been acquiring financing to fund a program of expansions and takeovers, preparing the way to dominate the American market. Organigram Holdings, Inc. (OTC: OGRMF) and Emerald Health Therapeutics (OTC: EMHTF) have both set up a string of supply agreements, giving them quick access to the Canadian recreational market come October.
To view an infographic of this editorial, click here.
Transforming Canada’s Cannabis Industry
On October 17, cannabis will become legal in Canada. Under the provisions of the Cannabis Act, Canadians will be able to buy and consume cannabis for recreational as well as medical purposes. Careful licensing, together with clear rules around cultivation and processing, will ensure that a previously illegal industry becomes a well-regulated part of the legal economy. As Prime Minister Trudeau said when the law was passed, “It’s been too easy for our kids to get marijuana — and for criminals to reap the profits. Today, we change that.”
The Cannabis Act promises to be a great boon to the Canadian economy. Since 2014, the Canadian medical cannabis industry has grown to include over 100 licensed companies, many of which will be able to expand their sales and research under the new rules. In a year’s time, further rules will come into force that allow the sale of concentrates and edible cannabis products, creating a cannabis food and drink industry. But one of the biggest changes will take place within the industrial hemp industry.
Cannabis without the High
While the term “cannabis” is most often used to refer to plants with psychoactive effects, it actually covers a broader range of crops. One of the most historically prevalent varieties of cannabis is industrial hemp, a form of cannabis grown by companies such as the Marijuana Company of America (OTC: MCOA).
Industrial hemp is distinct from more controversial forms of cannabis — marijuana — in that it does not contain tetrahydrocannabinol (THC), the active ingredient that gets users high, but rather it contains cannabidiol (CBD), which has recently grown in popularity due to its variety of medicinal benefits. Hemp was used for hundreds of years to produce fibers for cloth and rope and was widely grown in North America. But for most of the past century, it has been out of production thanks to broad-ranging anti-cannabis legislation.
The past few years have seen a resurgence for industrial hemp. Legislation created for the cultivation of medical marijuana has created the opportunity for companies such as MCOA to grow hemp in Canada. In the United States, the 2014 Farm Bill created legal space for trial crops of hemp. That bill’s 2018 successor appears set to make it entirely legal in the United States, allowing farmers to grow a highly profitable new crop.
The passing of the Cannabis Act will further improve the potential of hemp in Canada, as it will allow producers to extract cannabidiol (CBD). Cannabidiol is an active ingredient that’s commonly found in high concentrations in certain varieties of industrial hemp. It doesn’t have the psychoactive properties of THC but has been shown to have beneficial effects on health. As a result, it’s used in a growing variety of health and wellness products, including MCOA’s brand hempSMART.
Using the Whole Plant
Up until now, Canadian hemp producers have been limited in what they can do with the plant. The seeds could be extracted and used; fibers could be turned into textiles; and leftover elements known as hurds could be turned into either animal feed or construction materials. The use of leaves and flowers was specifically prohibited.
The Cannabis Act allows for a broader range of uses. Health Canada has proposed the introduction of new industrial hemp licenses to make this a reality. Under the proposed system, industrial hemp producers will be able to sell the whole plant or any of its parts to other licensed operators within the hemp industry. They could even process it themselves, extracting CBD oil as well as seeds, fibers and hurds.
It’s a change that will create a more efficient and profitable industry, as parts of the plant will no longer go to waste. And growing interest in CBD as a wellness ingredient could lead to a significant rise in income for hemp farmers. Companies such as MCOA, whose operations cover the whole industrial chain from hemp production to the sale of CBD products, will be able to build solid, sustainable supply chains that maximize profits at every step.
This is all before taking into account the possibility of agricultural subsidies. There is currently disagreement within Canada over whether cannabis growers will be eligible for subsidies under existing rules, but with the arrival of cannabis-based foods and beverages next year, lines will become increasingly blurry. MCOA and its joint venture partner, Global Hemp Group Inc., have received financial support from Canadian government agencies to research hemp cultivation. As the commercial landscape changes, hemp producers may soon find themselves eligible for even more government help.
Sowing the Seeds for a Growing Industry
MCOA’s growth in the Canadian hemp sector comes through its establishment of a high-yielding CBD hemp cultivation project in New Brunswick (NB). This collaboration with Global Hemp Group has revived hemp cultivation in the region 20 years after a previous effort failed.
The joint venture partners are in process of completion of the first phase of what is known as the Hemp Agro-Industrial Zone, or HAIZ. The aim of the HAIZ is to provide a steady supply of hemp by building a local industrial cluster, guaranteeing a market for farmers and leading to year-round jobs for others in the region. Through trial crops and careful measurement of the results, the project is providing valuable data on important issues such as pests, fertilizers and growth rates.
Recent developments at the site include the installation of drying equipment in preparation for processing. In the short term, this will allow the company to effectively store its current harvest until it can be sold and processed under the rules coming in October. In the longer term, it will increase its options for growing, processing and selling hemp. The joint venture partners are currently in the process of negotiating off-take agreements with extraction companies to sell the biomass produced during the October harvest in New Brunswick.
MCOA and its partners in New Brunswick have been finding ingenious ways to improve techniques impeded by decades outside the law. This year, the team in NB experimented with a modified bean harvester to strip leaves and flowers from the plants without picking up much straw. Based on the results, this technique is being extended to the entire 125-acre project.
Cannabis Cultivation Creates New Industry
In less than two decades, a whole new industry has grown up around the cultivation of hemp and other forms of cannabis. Even with restrictions still tight in much of the world, companies are finding ways to legally profit from these crops.
Isodiol International, Inc. (OTC: ISOLF) has become an important and active voice for the industry, employing former NFL player Marvin Washington as a director and spokesperson. The company has developed a variety of cannabis and CBD-derived products, tapping into the medical and vaping markets. Its KURE Corp subsidiary provides a strong retail front and has recently set its sights on further expansion through new and acquired shops.
A prominent player within the industry, Aurora Cannabis, Inc. (OTC: ACBFF) is making the most of a young market to rapidly expand its business. A $150 million loan from the Bank of Montreal is giving it a short-term financial boost to get ahead of the long-term game. It’s this sort of long-term thinking that has led the company to acquisitions such as the takeover of MedReleaf, increasing Aurora’s market share. Some commentators have compared this strategy with that of Amazon, focusing on market dominance as the route to profit.
Organigram Holdings, Inc. (OTC: OGRMF), a medical cannabis company, is preparing to expand into Canada’s recreational market in October. The company has established a number of agreements with other companies, most recently the Nova Scotia Liquor Corporation, to supply its products to stores. These agreements will ensure that the legal recreational market quickly grows from a principle to a reality.
Emerald Health Therapeutics (OTC: EMHTF) is also setting up supplier agreements to give it a place in the recreational starting lineup. Its partners include the Newfoundland Labrador Liquor Corporation and Ontario Cannabis Retail Corporation.
The Canadian cannabis industry is set to experience a transformation on October 17, one that will prepare companies to expand as laws change elsewhere in the world. From medical cannabis companies to hemp growers, many business enterprises are likely to profit from this change.
For more information on Marijuana Company of America, visit Marijuana Company of America, Inc. (OTC: MCOA)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
Source:
CannabisNewsWire
All eyes looking who's going to be the first to post the news?
NEWS PENDING!!!!
Shine JESUS Shine
Here’s a bunch of BS. Pot stocks drop after report that Canadian marijuana investors may be barred from U.S.
By Jeremy C. Owens
Published: Sep 13, 2018 5:23 pm ET
Cannabis-related stocks dropped in after-hours trading Thursday following a report that the U.S. may bar Canadians who invest in the companies from entering the U.S. Politico reported Thursday afternoon that an official with the U.S. Customs and Border Protection agency said that Canadians who smoke marijuana, work in the industry or invest in the companies could be permanently banned from the U.S. "Facilitating the proliferation of the legal marijuana industry in U.S. states where it is deemed legal or Canada may affect an individual's admissibility to the U.S.," Todd Owen, executive assistant commissioner for the Office of Field Operations at the CBP, told Politico. Marijuana use will officially become legal in Canada on Oct. 17. The CBP did not immediately respond to an email seeking to confirm the statements. Stocks that immediately declined in late trading included Tilray Inc. tlry+14.11% which declined more than 5%; Canopy Growth Corp. cgc-13.67% which dropped about 4%; and Cronos Group Inc. cron-10.29% which also fell about 4%.
Latest Farm Bill Developments Hold Out Hope for Hemp Farmers
Print
Alert
CannabisNewsWire Editorial Coverage: After years of wrangling, the U.S. Congress stands on the verge of legalizing the cultivation of industrial hemp.
Hemp is a variety of the cannabis sativa plant that doesn’t generate a psychoactive effect.
Traditionally used to produce cloth and rope, hemp can also now be used in wellness products and food.
Competing legislations by the House and Senate are being aligned with an anticipated September 30 deadline.
The legalization of hemp has cross-party support and appears likely to pass.
The expected change in U.S. law will be beneficial for companies such as Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile), which is already invested in industrial hemp and support for hemp growers. Across the border, Canopy Growth Corp. (NYSE: CGC) has established acres of Canadian hemp cultivation and gained financial backing that would support huge growth. Aurora Cannabis, Inc. (OTCQX: ACBFF) has also received substantial funding in the past few months, which will help its ongoing expansion effort. Hemp cultivation will provide plentiful CBD to be used by companies such as CV Sciences, Inc. (OTC: CVSI) as an ingredient in a wide and growing range of health and wellness products. All this growth is aided by support companies such as Terra Tech Corp. (OTC: TRTC), which provides equipment for cannabis cultivators.
To view an infographic of this editorial, click here.
Hemp: Caught Between Politics and Business
Industrial hemp is a crop with a strange history in the United States. For centuries, it was used to produce products such as ropes and sails, playing an integral part in the economy. This ended in the twentieth century when hemp was caught up in a broad ban on the cannabis family of plants, despite the fact that hemp itself is not usable as a recreational drug. Now its tentative return depends upon the outcome of a far broader agricultural bill.
Because it doesn’t share the psychoactive properties of marijuana, hemp has potential to be regulated and grown separately. Early tests in restoring this industry have produced significant profits for farmers. If the political will can be found to change its status, it could create great opportunities for businesses and their suppliers.
Hemp Cultivation Project in the United States
Several companies, including Marijuana Company of America (OTC: MCOA), are already growing hemp in the United States with their Scio, Oregon Cultivation Project, in conjunction with their joint venture partner Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG).
Under their high-yielding CBD hemp cultivation projects, the two joint venture partners have formed Covered Bridge Acres, LTD. The key to the project was the acquisition of a 109-acre agricultural property in Scio, Oregon, with a history of hemp cultivation over the past few years. In July 2018, 40,000 hemp clones were planted on the property for Cannabidiol (CBD) propagation on approximately 33 acres of the property.
MCOA and GHG are now in the process of evaluating different harvesting, drying, storage and processing strategies in preparation of an early October harvest. The joint venture partners are also in negotiations with guaranteed offtake agreement offers and are considering strategies involved with selling the attained biomass from harvest in bulk.
When Is a Drug Not a Drug?
Hemp is one of a range of different cannabis plants. Unlike the versions smoked by recreational users, it doesn’t contain significant quantities of tetrahydrocannabinol (THC), the chemical that gets smokers high. It does contain the active ingredient cannabidiol (CBD), which has been widely reported to have medicinal value — reports that now have been substantiated by the U.S. Food and Drug Administration. Importantly, hemp also contains fibers that can be used for a wide range of purposes.
In the twentieth century, cannabis plants were banned as the U.S. government and others worldwide cracked down on drug use. Though hemp doesn’t get drug users high, the governments apparently banned the cannabis plant because of the difficulty of distinguishing between the plant varieties. The decision to include hemp in a list of banned drugs was based on political expediency rather than science.
Fast forward to the twenty-first century and the rules surrounding hemp have started to change, allowing the creation of companies such as MCOA. Hemp has a huge number of potential uses, including the manufacture of cloth and paper and the processing of food. Under licenses designed to cater to research and the medical market, farmers have begun growing industrial hemp with expectations of earning up to 150 times as much money per acre of land as they would growing alfalfa.
The Great Agricultural Debate
Farm bills are an important part of how the U.S. government establishes policy around food and agricultural production and how that policy is enshrined in law. Roughly every five years, Congress creates a bill covering a wide range of agricultural topics. With its huge financial implications and many different political angles, passing the bill can be a messy business.
Following a pilot research program for hemp growers created in the 2014 Farm Bill, the current Farm Bill includes the legalization of industrial hemp. There’s a lot at stake for hemp growers as well as those hoping to enter and establish a foothold in the industry. The U.S. Hemp Roundtable has gone so far as to hire attorney Daniel Cameron, an experienced Washington legal counsel, to lead its advocacy on the bill.
The House and Senate have both passed versions of the 2018 Farm Bill that support the legalization of the hemp industry without drug enforcement oversight. On Sept. 5, the first bicameral conference committee on this Farm Bill began meeting in an attempt to resolve competing elements between the two bills, with a deadline to present the president with an agreed-on final version of the bill by the end of the month.
The good news for companies such as MCOA is that the hemp element of the Farm Bill has cross-party support. Hemp’s potential to revive the fortunes of American farmers makes it a potential vote-winner for rural politicians nervously eyeing up the polls. The bad news is that in a bill affecting everything from agricultural subsidies to environmental conservation to food stamps, there’s plenty for politicians to disagree over.
Hemp Products
Sail cloth and rigging were enough to make hemp profitable in the eighteenth century, but the world has changed since then. So what sort of products can the world expect to see from a resurgent hemp market?
Many products will undoubtedly be targeted towards the health and wellness market, using CBD as an active ingredient. A leading example of these types of products is MCOA’s hempSMART line, including hempSMART Brain, which is developed to help with alertness and concentration; hempSMART Pain Capsules and Pain Cream, formulated to be an effective product combination for the temporary relief of minor pain associated with physical activity; hempSMART Full Spectrum Drops; and hempSMART Face, a nourishing facial moisturizer infused with Ayurvedic herbs and botancials.
A Growing Industry
Many companies already engaged in the cannabis market are exploring ways they may be able to benefit from the growing popularity of hemp. Canopy Growth Corp. (NYSE: CGC), one of Canada’s foremost cannabis companies, has a hemp division with expertise in this area and acres of hemp production already under way. The company also recently received a $4 billion investment from Constellation Brands, a leading beverage company, to help it expand within the fast-growing cannabis market. With such levels of investment, Canopy Growth will be in a strong position to increase production as the market for hemp products grows.
The medical use of CBD is a major area of interest for Aurora Cannabis, Inc. (OTCQX: ACBFF), which is developing different strains of cannabis to benefit from their different medical properties. Like Canopy Growth, Aurora has an eye to expansion while the market is still young. Its recent takeover of MedReleaf appears to be just one step in a far bigger plan. The company has just taken out a $150 million loan with the Bank of Montreal, betting on the power of a short-term financial boost to make it a market leader, more than capable of repaying the debt when the time comes.
Another company exploring the medical potential of CBD is CV Sciences, Inc. (OTC: CVSI). CV Sciences has a strong focus on research, with a division devoted to developing new drugs that use CBD as an active ingredient. Its consumer products division works through health care providers, health food shops and online sales to market CBD-based wellness products.
The increasing number of growers is good news for supporting companies such as Terra Tech Corp. (OTC: TRTC). Terra Tech produces growing systems — including moving tables and hydroponics — for cannabis farmers. These products are designed to increase the productivity of indoor cannabis cultivation, which is where a lot of CBD and marijuana plants are grown. The company’s environmentally friendly systems can reduce waste and thereby cut costs while also increasing productivity.
The anticipated changes in the U.S. laws governing hemp cultivation signal implications for a large number of companies in the wider cannabis sector as well. If the Farm Bill gets through Congress as expected this month, it could open up a sea change in agricultural production and U.S. wellness industry products.
For more information on Marijuana Company of America, visit Marijuana Company of America, Inc. (OTC: MCOA)
Today I'm back in the green. Lets keep it going. Go Emblem.
Thanks for the post Macman, let’s go Emblem.
Looks like another beautiful day. Keep posting Clay your doing welll. Lol
If this keeps up, anyone want to take a shot at where we might be on Oct.17th. I'll stick my neck out and say just north of $20, and then when the rest of the world catches on only one knows. So many minds occupied by daily chores, sitting behind desks trying to please their bosses. How many are clueless to what is about to take place. Congrats to those who are here now. Many eyes are watching but many more are not, but soon will be. All just my opinion.
Question is has the tide turned. Who's waiting until mid-October to buy. Could be too late to jump in here. Many new investors will be coming post legalization. IMO smart money will be jumping in now, and let the new investors take us even higher. Started buying Aurora early and have a nice position here. Would love to see Aurora become the next Amazon or Google. GLTA
Call this company what you want I’m not gonna reply again until I see this thing over $10. Lowering my price per share as the price drops for the next wave. GLTY
Get your facts straight and I personally don’t care what you do. A Colorado Springs company that leases property to the marijuana industry has sued one of its investors, claiming he was the reason its stock was delisted from over-the-counter trading last spring.
Advanced Cannabis Solutions says in a federal lawsuit filed in U.S. District Court in Denver that Stephen Calandrella, president of Colorado Springs-based The Rockies Fund Inc., quietly bought and sold ACS stock without letting the company know he controlled more than 10 percent of its shares, a requirement of federal securities law.
The lawsuit claims Calandrella held as much as 13 percent of ACS stock, personally and through The Rockies Fund he controls. It claims he made more than a dozen trades between August 2013 and January, short-swing trades that occur within a six-month period and prohibited to those who own more than 10 percent of a publicly traded company’s stock.
Call it what you want WallWeeD. Yes they where on the greys only because one person sold their shares without the companies knowledge. Advanced Cannabis Solution took the guy to court and won. Stock jumped from about a dollar to almost ten when that news came out. Scam is such an ugly word for how far this company has come. I have done very well trading this stock. Just the fact that "OTC Markets Group Welcomes General Cannabis to OTCQX" makes me feel comfortable here. Scams don't come back from being on the greys. Say hi to Stockzoom for me.
Thanks 3-day. GLTU
What is going on with this company? Either they are incompetent, or something big is about to happen. Only Biocept is benefiting here. Biocept better be doing right by its shareholders. These patents mean nothing if they can't produce a marketable product. They will have to feed us some news by early Mar. when fins come out.
Time to load up.
Nice to see some posts on this board. I've been a lonely goat here for quite some time. Hope this thing moves quick, would be nice.
My pps is a little over $1, not too excited. Averaged down with what I had left in savings. GLTU
Stockzoom's post #3951.
LOL..This scam is worth zero if you try to really value it based on current financials. It is the hyp of MJ that is keeping this at 0.6, or this junk will be at 3-4 cents..Look at the financials
Did you even read it ?
I can't believe people think this company has nay future. You are linking MJ explosion to a failed turd like this...Yeah MJ..look at the losses..what a scam !
Revenue exposes it all
Their only way to survive is dilute and thrive
I see this falling to 5-10 cents as they dump more shares to survive
How's this working out for a ya Zoom? You can't even spell "any" right. So .60 is going to less than .10, so with your predictions this should be around $36 in the near future. I'll remind you of this post when we get there. Stop entertaining us by looking stupid, or just post current facts if your capable.
Good morning all Cann share holders.
If your hitting the ask shouldn't be a problem.
Shorts can pusher down, but can't keep her down. Strong like bull, built for CANN.
Thank you. I've got plenty still invested here, never took it all out. GLTY
I'm with ya on that. Stockzoom showed up yesterday on one of the biggest Canadian MJ stocks talking his same old story.
I understand. I am not a day-trader and reading charts is beyond my education. So for me when you post helpful information it means a lot to us individuals that have a daily job routine. So any thoughts on your past experiences are we looking good here?
If you look at the number of posts here lately you see I have been a lonely stock holder in this company. Usually ever time I do one thing the opposite happens. I'm still here and watching this company closely, waiting for the last leg up on the chart. Thanks for posting.
Pay no attention to stockzome. He's all over the US marijuana stocks as well. He was blowing smoke when one of my U.S.mj stocks was less than a dollar, todays it's over $9. I have a nice position here and letting it ride.
Thanks for sharing that link. Just a matter of time mj gets rescheduled and cann will continue to improve. A few more quarters here we could be golden.
Get a life. Shouldn't you be out of posts for the day.
General cannabis announces pay down of 12% notes that were due by Sept. 2018. The link is in Seeking Alpha.
Zoom, did you change your name and not tell us. Been here at less than a dollar. Your comments are worthless 2 a lot of us. 3 years ago this company was too young to sustain its market price. But now their roots are growing deeper and numbers are improving (not great) just getting better. Good luck, ZOOM ZOOM. By that I mean move on.
Don't know, but happy to be making money here once it got past $1.48. GLTA
Pulled my money out and took a loss, looking at much better gains in MJ. Happy New Year.
Congrats to those that are still here that believed in this company back when we where posting around .50. Prosperous and healthy New Year to all.